# Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

> **NCT00812955** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 474 (actual)

## Conditions studied

- Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia

## Interventions

- **DRUG:** ABT-143
- **DRUG:** simvastatin

## Key facts

- **NCT ID:** NCT00812955
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2012-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812955, "Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00812955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*